Jo Caers
Caers, Jo
VIAF ID: 142155284775287061009 (Personal)
Permalink: http://viaf.org/viaf/142155284775287061009
Preferred Forms
- 100 1 _ ‡a Caers, Jo
-
- 100 0 _ ‡a Jo Caers
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde | |
Ac-SDKP: linking cardiac remodeling to hematological malignancies | |
Acute interstitial nephritis associated with salmonellosis. | |
Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents? | |
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. | |
Bone mass of the calvarium. | |
Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports | |
Cellular immunotherapy in multiple myeloma: lessons from preclinical models | |
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. | |
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. | |
Diffuse xanthomatosis as a presenting feature of multiple myeloma | |
Dual-tracer PET/CT scan after injection of combined [18 F]NaF and [18 F]FDG outperforms MRI in the detection of myeloma lesions | |
The effects of forodesine in murine and human multiple myeloma cells | |
Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma | |
Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation | |
Exome copy number variation detection: Use of a pool of unrelated healthy tissue as reference sample | |
Extramedullary disease in multiple myeloma: a systematic literature review | |
Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer | |
A First Report on [18F]FPRGD2 PET/CT Imaging in Multiple Myeloma | |
Galectin expression in cancer diagnosis and prognosis: A systematic review. | |
Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexity. | |
Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma | |
Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide | |
Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study | |
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation | |
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts | |
Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factors | |
Molecular mechanisms, current management and next generation therapy in myeloma bone disease. | |
Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells | |
A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease | |
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA) | |
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group | |
Prise en charge actuelle des syndromes myélodysplasiques | |
[Retroperitoneal fibrosis and multiple myeloma: fortuitous association?] | |
The Road to a Cure: Emerging Treatments for Multiple Myeloma | |
The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma. | |
SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma. | |
Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma | |
Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis |